Abstract
Membrane contact sites (MCSs) are adjacent locations between the membranes of two different organelles and play important roles in various physiological processes, including cellular calcium and lipid signaling. In cancer research, MCSs have been proposed to regulate tumor metabolism and fate, contributing to tumor progression, and this function could be exploited for tumor therapy. However, there is little evidence on how MCSs are involved in cancer progression. In this review, we use extended synaptotagmins (E-Syts) as an entry point to describe how MCSs affect cancer progression and may be used as new diagnostic biomarkers. We then introduced the role of E-Syt and its related pathways in calcium and lipid signaling, aiming to explain how MCSs affect tumor proliferation, progression, metastasis, apoptosis, drug resistance, and treatment through calcium and lipid signaling. Generally, this review will facilitate the understanding of the complex contact biology of cancer cells.
Introduction: Membrane Contact Sites as Regulatory Hubs
In traditional cell biology, organelles were often viewed as isolated compartments. However, modern research has revealed a sophisticated network of communication known as Membrane Contact Sites (MCSs). These are specialized regions where the membranes of two different organelles are positioned in close proximity (typically 10–30 nm) without undergoing fusion. This review, published in Frontiers in Cell and Developmental Biology, explores how these physical bridges act as critical regulatory hubs, with a specific focus on the Extended Synaptotagmin (E-Syt) family and their role in cancer progression.
The E-Syt Family: Dynamic Molecular Tethers
The E-Syt family consists of three members (E-Syt1, E-Syt2, and E-Syt3) that serve as essential "communication ports" between the endoplasmic reticulum (ER) and the plasma membrane (PM). These proteins are not merely static structural components; they are dynamic, calcium-dependent tethers that allow tumor cells to manipulate calcium levels and lipid compositions to favor rapid proliferation.
Structurally, E-Syts are characterized by two primary functional domains:
- SMP Domain: Forms a hydrophobic groove that shuttles phospholipids between membranes, allowing for the rapid remodeling of the plasma membrane to facilitate metastasis.
- C2 Domains: Act as calcium sensors. When cytosolic calcium rises, the C2 domains of E-Syt1 bind to the PM, physically pulling the ER closer to the cell surface to enhance signaling efficiency.
Metabolic Reprogramming and the Warburg Effect
A central mechanism discussed is the interaction between E-Syts and the Store-Operated Calcium Entry (SOCE) pathway, involving proteins like STIM1 and Orai1. By stabilizing ER-PM junctions, E-Syts facilitate the calcium signaling that drives the Warburg Effect—the metabolic shift where cancer cells favor rapid glycolysis over oxidative phosphorylation to provide raw materials for biomass production.
Clinical Implications and Future Directions
The review highlights several significant findings linking MCS activity to clinical outcomes:
- Diagnostic Markers: STIM1 and Orai1 are consistently upregulated in thyroid, breast, and lung cancers. Lipid profiles in urinary exosomes, likely regulated by MCS activity, show promise as non-invasive biomarkers for prostate cancer.
- Drug Resistance: MCSs contribute to Multidrug Resistance (MDR) by altering membrane lipid fluidity, making it harder for chemotherapy drugs to penetrate the cell. Additionally, anti-apoptotic proteins like Bcl-2 can block cisplatin-induced death by modulating calcium signaling at ER-mitochondria contact sites.
While the roles of E-Syt1 and E-Syt2 are becoming clearer, the function of E-Syt3 remains a mystery. The authors call for a holistic "contact biology" approach to cancer research, moving beyond single-protein studies to look at the entire interactome of organelle junctions to develop precise therapeutic targets.
Summary updated